The natural world is an expansive laboratory of chemical innovation, producing a staggering variety of compounds that plants use to navigate their environments, defend against predators, and communicate with neighboring species. Many of these natural products are highly specific, appearing only within narrow ancestral lineages or even restricted to a single species. However, every so often, nature performs a remarkable feat of repetition. In a discovery that highlights the ingenuity of evolutionary biology, researchers have elucidated the biosynthetic pathway of ipecacuanha alkaloids, demonstrating how two plant species separated by over 100 million years of evolution independently developed the same complex chemical defense system.
This breakthrough, led by scientists at the Max Planck Institute for Chemical Ecology in Jena, Germany, focuses on a group of compounds known as ipecacuanha alkaloids. These substances are perhaps most famous for their presence in the ipecac plant, Carapichea ipecacuanha, a member of the Rubiaceae family, which also includes coffee and quinine. Ipecac, native to the rainforests of Central and South America, has a long history in traditional and modern medicine. Its most well-known application was "Ipecac syrup," a common fixture in North American and European pharmacies until the late 20th century. The syrup was used as an emetic to induce vomiting in emergency cases of accidental poisoning, a medical staple that relied on the potent biological activity of the plant’s primary alkaloids: cephaelin and emetine.
While the ipecac plant is the most famous source of these compounds, it is not the only one. Interestingly, the same alkaloids are found in the sage-leaved alangium, Alangium salviifolium, a tree native to parts of Asia and Africa. Alangium salviifolium belongs to the Cornaceae, or dogwood family, and has been a cornerstone of Ayurvedic medicine for centuries, used to treat everything from skin diseases to snakebites. Despite their shared chemical repertoire, these two plants are only distantly related. Their last common ancestor lived during the Cretaceous period, more than 100 million years ago, a time when dinosaurs still dominated the landscape. This vast evolutionary gap raised a fundamental question for scientists: did these two plants inherit the ability to make these chemicals from a common ancestor, or did they "reinvent the wheel" independently?
Maite Colinas, the first author of the study and a project group leader in the Department of Natural Product Biosynthesis at the Max Planck Institute, spearheaded the effort to solve this mystery. Colinas and her colleagues hypothesized that the two species had undergone convergent evolution—a process where different organisms independently evolve similar traits as a result of having to adapt to similar environments or ecological niches. In this case, the trait was the complex multi-step chemical assembly line required to produce ipecacuanha alkaloids. The key to proving this was to determine whether the plants used the same enzymes and genetic pathways to reach the same chemical end goal.
The research team began by mapping where these alkaloids are produced within the plants. They discovered that while the compounds are present throughout the tissues of both species, the highest concentrations are found in young, developing leaves and in the underground organs, such as roots and rhizomes. This distribution is typical for defensive compounds, as plants tend to invest their chemical protection in their most vulnerable or valuable parts. By comparing tissues with high concentrations of the alkaloids to those with low concentrations, the researchers were able to identify the genes that were most active during the production process. This comparative approach allowed them to narrow down the list of candidate enzymes involved in the biosynthesis.
